Positive clinical outcomes derived from using Streptococcus salivarius K12 to prevent streptococcal pharyngotonsillitis in children: a pilot investigation
Francesco Di Pierro,1 Maria Colombo,2 Alberto Zanvit,3 Amilcare S Rottoli,4 1Scientific Department, Velleja Research, Milan, 2Pediatric Department, University of Parma, Parma, 3Stomatology Institute, 4Pediatric Department, Uboldo Hospital, Cernusco S/N, Milan, Italy Background: Streptococcus salivar...
Main Authors: | Di Pierro F, Colombo M, Zanvit A, Rottoli AS |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016-11-01
|
Series: | Drug, Healthcare and Patient Safety |
Subjects: | |
Online Access: | https://www.dovepress.com/positive-clinical-outcomes-derived--from-using-streptococcus-salivariu-peer-reviewed-article-DHPS |
Similar Items
-
Reduction of group A beta-hemolytic streptococcus pharyngo-tonsillar infections associated with use of the oral probiotic Streptococcus salivarius K12: a retrospective observational study
by: Gregori G, et al.
Published: (2016-01-01) -
New probiotic strain Streptococcus salivarius K12 in clinical practice
by: Andreeva I.V., et al.
Published: (2019-10-01) -
The effectiveness of using respiratory probiotic Streptococcus salivarius K12 in children with recurrent tonsillitis
by: S.I. Ilchenko, et al.
Published: (2020-03-01) -
Inhibitory effect of Streptococcus salivarius K12 and M18 on halitosis in vitro
by: Hyun‐Jun Yoo, et al.
Published: (2020-04-01) -
Pilot study to explore the prophylactic efficacy of oral probiotic Streptococcus salivarius K12 in preventing recurrent pharyngo-tonsillar episodes in pediatric patients
by: Marini G, et al.
Published: (2019-06-01)